- 1D
- 3D
- 1W
- 1M
- 6M
- 1Y
- 3Y
- 5Y
Announcements
- Result of AGM
- Holding(s) in Company
- Notice of AGM & Annual Report & Accounts
- Final Results
- Realisation-c£1.5m on sale of shares in Incanthera
- IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
More ▼
Key statistics
On Friday, ImmuPharma PLC (IMM:LSE) closed at 2.08, -30.67% below its 52-week high of 3.00, set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.16 |
---|---|
High | 2.16 |
Low | 2.10 |
Bid | 1.96 |
Offer | 2.30 |
Previous close | 2.13 |
Average volume | 631.53k |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 8.87m GBP |
EPS (TTM) | -0.0081 GBP |
Data delayed at least 20 minutes, as of Jun 28 2024 16:12 BST.
More ▼